Abstract
Autonomous self-propelled catalytic microjets are envisaged as an important technology in biomedical applications, including drug delivery, micro/nanosurgery, and active dynamic bioassays. The direct in vivo application of these microjets, specifically in blood, is however impeded by insufficient knowledge on the in vivo viability of the technique. This study highlights the effect of blood proteins on the viability of the microjets. The presence of blood proteins, including serum albumin and γ-globulins at physiological concentrations, has been found to dramatically reduce the viability of the microjets. The reduction of viability has been measured in terms of a lower number of active microjets and a decrease in the velocity of propulsion. It is clear from this study that in order for microjets to function in biomedical applications, different modes of propulsion besides platinum-catalyzed oxygen bubble ejection must be employed. These findings have serious implications for the biomedical applications of catalytic microjets.
| Original language | English |
|---|---|
| Pages (from-to) | 16756-16759 |
| Number of pages | 4 |
| Journal | Chemistry - A European Journal |
| Volume | 19 |
| Issue number | 49 |
| DOIs | |
| Publication status | Published - 2013 Dec 2 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Catalysis
- Chemistry(all)
- Organic Chemistry
Cite this
}
Blood proteins strongly reduce the mobility of artificial self-propelled micromotors. / Wang, Hong; Zhao, Guanjia; Pumera, Martin.
In: Chemistry - A European Journal, Vol. 19, No. 49, 02.12.2013, p. 16756-16759.Research output: Contribution to journal › Article
TY - JOUR
T1 - Blood proteins strongly reduce the mobility of artificial self-propelled micromotors
AU - Wang, Hong
AU - Zhao, Guanjia
AU - Pumera, Martin
PY - 2013/12/2
Y1 - 2013/12/2
N2 - Autonomous self-propelled catalytic microjets are envisaged as an important technology in biomedical applications, including drug delivery, micro/nanosurgery, and active dynamic bioassays. The direct in vivo application of these microjets, specifically in blood, is however impeded by insufficient knowledge on the in vivo viability of the technique. This study highlights the effect of blood proteins on the viability of the microjets. The presence of blood proteins, including serum albumin and γ-globulins at physiological concentrations, has been found to dramatically reduce the viability of the microjets. The reduction of viability has been measured in terms of a lower number of active microjets and a decrease in the velocity of propulsion. It is clear from this study that in order for microjets to function in biomedical applications, different modes of propulsion besides platinum-catalyzed oxygen bubble ejection must be employed. These findings have serious implications for the biomedical applications of catalytic microjets.
AB - Autonomous self-propelled catalytic microjets are envisaged as an important technology in biomedical applications, including drug delivery, micro/nanosurgery, and active dynamic bioassays. The direct in vivo application of these microjets, specifically in blood, is however impeded by insufficient knowledge on the in vivo viability of the technique. This study highlights the effect of blood proteins on the viability of the microjets. The presence of blood proteins, including serum albumin and γ-globulins at physiological concentrations, has been found to dramatically reduce the viability of the microjets. The reduction of viability has been measured in terms of a lower number of active microjets and a decrease in the velocity of propulsion. It is clear from this study that in order for microjets to function in biomedical applications, different modes of propulsion besides platinum-catalyzed oxygen bubble ejection must be employed. These findings have serious implications for the biomedical applications of catalytic microjets.
UR - http://www.scopus.com/inward/record.url?scp=84889660684&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84889660684&partnerID=8YFLogxK
U2 - 10.1002/chem.201301906
DO - 10.1002/chem.201301906
M3 - Article
C2 - 24166769
AN - SCOPUS:84889660684
VL - 19
SP - 16756
EP - 16759
JO - Chemistry - A European Journal
JF - Chemistry - A European Journal
SN - 0947-6539
IS - 49
ER -